Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease

2010 ◽  
Vol 66 (3) ◽  
pp. 256-264 ◽  
Author(s):  
Ana Marcia Delattre ◽  
Ágata Kiss ◽  
Raphael E. Szawka ◽  
Janete A. Anselmo-Franci ◽  
Pamela Brambilla Bagatini ◽  
...  
2010 ◽  
Vol 52 (2) ◽  
pp. 263-271 ◽  
Author(s):  
Melanie Bousquet ◽  
Karl Gue ◽  
Vincent Emond ◽  
Pierre Julien ◽  
Jing X. Kang ◽  
...  

2011 ◽  
Vol 10 (4) ◽  
pp. 453-463 ◽  
Author(s):  
Mélanie Bousquet ◽  
Frédéric Calon ◽  
Francesca Cicchetti

2017 ◽  
Vol 120 (6) ◽  
pp. 523-531 ◽  
Author(s):  
Alexandre Sales Barros ◽  
Rafael Yuri Gouveia Crispim ◽  
Juliana Uchoa Cavalcanti ◽  
Ricardo Basto Souza ◽  
Jonatas Cavalcante Lemos ◽  
...  

Author(s):  
OJS Admin

Parkinson's disease is a neurodegenerative disease and no proper treatment or cure has been developed for it till now. Worldwide the incidence of disease has been increased with age. Latest researches have focused on the dietary aspects of Parkinson's and have revealed that a ketogenic diet may be benecial in prevention and for therapy. The main aim of this review article was to explore the dietary elements present in ketogenic diet and their respective roles in the body with link to Parkinson's disease. Ketogenic diet has been used in many neurological diseases due to its neuroprotective effects. Ketogenic diet is a normal caloric diet that composed of with high fat (mostly composed with polyunsaturated fatty acids), medium protein and low in carbohydrates. The composition of this diet makes body to utilize fatand ketones for energy by altering glucose. The major constituents present in a ketogenic diet which have neuroprotective effects against Parkinson's are; B complex vitamins, Omega-3 Fatty Acids, Omega-6 Fatty acids and Vitamin D. The benecial effects have been evaluated regarding the role of constituents present in a ketogenic diet on Parkinson's disease. The need for further researches, especially clinical trials forthe different constituents of ketogenic diet and their neuroprotective properties are still required.


Author(s):  
Hadeer Zakaria ◽  
Tarek M. Mostafa ◽  
Gamal A. El-Azab ◽  
Nagy AH Sayed-Ahmed

Abstract. Background: Elevated homocysteine levels and malnutrition are frequently detected in hemodialysis patients and are believed to exacerbate cardiovascular comorbidities. Omega-3 fatty acids have been postulated to lower homocysteine levels by up-regulating metabolic enzymes and improving substrate availability for homocysteine degradation. Additionally, it has been suggested that prevention of folate depletion by vitamin E consumption decreases homocysteine levels. However, data on the effect of omega-3 fatty acids and/or vitamin E on homocysteine levels and nutritional status have been inconclusive. Therefore, this study was planned to examine the effect of combined supplementation of fish oil, as a source of omega-3 fatty acids, with wheat germ oil, as a source of vitamin E, on homocysteine and nutritional indices in hemodialysis patients. Methods: This study was a randomized, double-blind, placebo-controlled trial. Forty-six hemodialysis patients were randomly assigned to two equally-sized groups; a supplemented group who received 3000 mg/day of fish oil [1053 mg omega-3 fatty acids] plus 300 mg/day of wheat germ oil [0.765 mg vitamin E], and a matched placebo group who received placebo capsules for 4 months. Serum homocysteine and different nutritional indices were measured before and after the intervention. Results: Twenty patients in each group completed the study. At the end of the study, there were no significant changes in homocysteine levels and in the nutritional indices neither in the supplemented nor in the placebo-control groups (p > 0.05). Conclusions: Fish oil and wheat germ oil combination did not produce significant effects on serum homocysteine levels and nutritional indices of hemodialysis patients.


Sign in / Sign up

Export Citation Format

Share Document